NCT04327011 2020-03-30A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511Tocagen Inc.Phase 1 Terminated65 enrolled
NCT02576665 2020-02-07A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)Tocagen Inc.Phase 1 Terminated21 enrolled